FX-322 in Adults With Stable Sensorineural Hearing Loss

Status Completed

Clinical Trial Summary

This is a phase 2a single and repeat dose exploratory efficacy study of intratympanic FX-322 compared to placebo in healthy male and female adults with stable sensorineural hearing loss.

Clinical Trial Description

Sensorineural hearing loss (SNHL) accounts for about 90% of all cases of hearing loss. This phase 2a study will assess the exploratory efficacy, as well as the local and systemic safety of single and repeat intratympanic doses of FX-322 compared to placebo in approximately 96 subjects with stable mild to moderately severe sensorineural hearing loss, with a medical history consistent with either excessive noise exposure or idiopathic sudden sensorineural hearing loss. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04120116
Study type	Interventional
Source	Frequency Therapeutics
Contact
Status	Completed
Phase	Phase 2
Start date	October 4, 2019
Completion date	December 17, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00023036` - Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Completed	`NCT03746613` - Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques	N/A
Recruiting	`NCT05568329` - Appreciation for Music Processed by Hearing Aids	N/A
Withdrawn	`NCT05061758` - A Trial of LY3056480 in Patients With SNLH	Phase 2
Completed	`NCT01434446` - The Effect of Sound Stimulation on Hearing Ability	N/A
Completed	`NCT03212924` - Listening Effort in Cochlear Implant Users	N/A
Recruiting	`NCT06053190` - Effects of Clear Speech on Listening Effort and Memory in Sentence Processing	N/A
Completed	`NCT03718975` - Quality Control of CE-Certified Phonak Hearing Aids - 2018_28	N/A
Completed	`NCT06025097` - Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.	Early Phase 1
Recruiting	`NCT04102215` - The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure	N/A
Recruiting	`NCT04108598` - The SeaSHeL National Prospective Cohort Study
Active, not recruiting	`NCT04750642` - Cochlear Implant With Dexamethasone Eluting Electrode Array	N/A
Recruiting	`NCT06223724` - Status Telemetry for Cochlear Implantations
Completed	`NCT02005822` - Congenital Cytomegalovirus: Efficacy of Antiviral Treatment	Phase 3
Suspended	`NCT02616172` - Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss	Phase 1/Phase 2
Completed	`NCT02259595` - Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC	Phase 1
Unknown status	`NCT01902914` - Effectiveness of P02 Digital Hearing Aids	Phase 1/Phase 2
Completed	`NCT00589511` - Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study	N/A
Completed	`NCT03288753` - Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors	N/A
Completed	`NCT04462198` - Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss	Phase 1/Phase 2